Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | NQO2 | P16083 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6741393 | 1.00 | APP (0.37) | APPCYP19A1MAOAMAOBNQO2 | |
| SCHEMBL10888410 | 0.92 | APP (0.43) | APPCYP19A1MAOAMAOBNQO2 | |
| SCHEMBL10888415 | 0.92 | APP (0.43) | APPCYP19A1MAOAMAOBNQO2 | |
| SCHEMBL1170340 | 0.89 | CA1 (0.37) | MAOAMAOBKDM4EALDH1A1KMT2A | |
| SCHEMBL12175796 | 0.88 | MEN1 (0.36) | APPCYP19A1MAOAMAOBNQO2 | |
| SCHEMBL30619970 | 0.88 | MEN1 (0.36) | APPCYP19A1MAOAMAOBNQO2 | |
| SCHEMBL13062393 | 0.87 | PTGS1 (0.40) | KDM4EALDH1A1KMT2A | |
| SCHEMBL13354269 | 0.86 | TTR (0.35) | KDM4EALDH1A1KMT2A | |
| SCHEMBL15762941 | 0.86 | CYP19A1 (0.47) | APPCYP19A1NQO2 | |
| SCHEMBL36940 | 0.84 | KDM4E (0.43) | APPKDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040019-B2 | Methods of detecting myelin basic protein | GENERAL ELECTRIC COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-9040019-B2 | Methods of detecting myelin basic protein | GENERAL ELECTRIC COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-8772048-B2 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | KENT STATE UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| US-20140154178-A1 | METHODS OF DETECTING MYELIN BASIC PROTEIN | GENERAL ELECTRIC COMPANY (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140154178-A1 | METHODS OF DETECTING MYELIN BASIC PROTEIN | GENERAL ELECTRIC COMPANY (US) | 2014-06-05 | — | — | US | disclosed |
| US-20120190098-A1 | FLUOROGENIC COMPOUNDS CONVERTED TO FLUOROPHORES BY PHOTOCHEMICAL OR CHEMICAL MEANS AND THEIR USE IN BIOLOGICAL SYSTEMS | LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-07-26 | — | — | US | disclosed |
| US-8153446-B2 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | KENT STATE UNIVERSITY (US) | 2012-04-10 | — | — | US | disclosed |
| US-20100029952-A1 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | KENT STATE UNIVERSITY (US) | 2010-02-04 | — | — | US | disclosed |
| US-6730929-B2 | Organic electroluminescent device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2004-05-04 | — | — | US | disclosed |
| US-20040061108-A1 | Organic electroluminescent device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| US-20010005021-A1 | Organic electroluminescent device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. | 2001-06-28 | — | — | US | disclosed |
| EP-1111695-A2 | Organic electroluminescent device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2001-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140154178-A1 | METHODS OF DETECTING MYELIN BASIC PROTEIN | MAG, PMP22, MYT1 | APP 1095/4885CYP19A1 4865/4885MAOA 3744/4885 |
| US-20120190098-A1 | FLUOROGENIC COMPOUNDS CONVERTED TO FLUOROPHORES BY PHOTOCHEMICAL OR CHEMICAL MEANS AND THEIR USE IN BIOLOGICAL SYSTEMS | MPI, ACR, PFAS | APP 2408/4885CYP19A1 3221/4885MAOA 456/4885 |
| US-20100029952-A1 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | MPI, ACR, PFAS | APP 2408/4885CYP19A1 3221/4885MAOA 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.